Treatment of congenital generalized lymphangiectasia with propranolol in a preterm infant.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 24446440.
- Also identified by DOI 10.1542/peds.2012-2087.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Generalized lymphangiectasia is a rare congenital disorder characterized by dilated lymphatic vessels with a fatal prognosis, especially in cases with thoracic involvement. We describe the use of propranolol in the therapy of generalized lymphangiectasia in a preterm infant with hydrops fetalis. Propranolol was well tolerated and effective within the first months. It remains to be shown whether propranolol is a treatment option for infants with generalized lymphangiectasia.
Medical subject headings
- Infant, Premature, Diseases
- Lymphangiectasis
- Propranolol